Microbial infections complicate the treatment of surface wounds and continue to pose a significant health and clinical complication. Infection of a wound with bacteria delays healing, and may even cause potentially fatal systemic infections, as well as increasing the issue of antibiotic resistance. The World Health Organization states that each year millions of individuals have infected wounds and the number of deaths caused by burn-related complications is in the thousands, which is preventable. Due to the emergence of multi-drug-resistant bacteria, there is an increasing demand for in-depth and more efficient wound work. To address this, We have designed polymer-based wound dressings that contain Clindamycin, a known antimicrobial agent. The polymer structure forms a porous and supportive structure that assists in moisture retention, oxygen diffusion, as well as tissue healing. When Clindamycin was incorporated into this structure, the drug was slowly released, which gave the dressings a long duration of protection against a vast range of bacteria and decreased the likelihood of developing side effects. Experimentally, the dressings have proven to inhibit the growth of gram-negative and gram-positive bacteria. Furthermore, The scaffolds have exhibited better In-Vitro and In-Vivo results. Clindamycin based polymer dressings are a potential combination of infection control and tissue support in the management of complex and infected wounds. This approach could provide a safer and better alternative to traditional wound treatments, particularly during the times of increasing antibiotic resistance.